Comparing Intra-Articular Injections of Hyaluronic Acid versus Platelet Rich Plasma for Osteoarthritis Knee Pain by Wong, Dawn G.
University of the Pacific 
Scholarly Commons 
Physician's Assistant Program Capstones School of Health Sciences 
4-1-2019 
Comparing Intra-Articular Injections of Hyaluronic Acid versus 
Platelet Rich Plasma for Osteoarthritis Knee Pain 
Dawn G. Wong 
University of the Pacific, dawn.g.wong@gmail.com 
Follow this and additional works at: https://scholarlycommons.pacific.edu/pa-capstones 
 Part of the Medicine and Health Sciences Commons 
Recommended Citation 
Wong, Dawn G., "Comparing Intra-Articular Injections of Hyaluronic Acid versus Platelet Rich Plasma for 
Osteoarthritis Knee Pain" (2019). Physician's Assistant Program Capstones. 44. 
https://scholarlycommons.pacific.edu/pa-capstones/44 
This Capstone is brought to you for free and open access by the School of Health Sciences at Scholarly Commons. 
It has been accepted for inclusion in Physician's Assistant Program Capstones by an authorized administrator of 
Scholarly Commons. For more information, please contact mgibney@pacific.edu. 
brought to you by COREView metadata, citation and similar papers at core.ac.uk
provided by Scholarly Commons
 1  
 
 
Comparing Intra-Articular Injections of Hyaluronic Acid versus Platelet Rich Plasma for 








Submitted to the Faculty of the 
Department of Physician Assistant Education 
of University of the Pacific 
in partial fulfillment of the requirements 
for the degree of  
MASTER OF PHYSICIAN ASSISTANT STUDIES 
 
 
April 2019  
 2  
ABSTRACT 
Purpose: To compare the efficacy of intra-articular (IA) injections of hyaluronic acid (HA) 
viscosupplementation to platelet-rich plasma (PRP) for degenerative osteoarthritis (OA) knee 
pain and function  
Methods: A review of current high-level evidence research articles on the subject matter 
Results: PRP is more effective than HA injections for mild knee OA, but there are no significant 
differences between PRP and HA in effectiveness for more advanced knee OA. Combination 
therapy of HA and PRP is superior to PRP or HA alone. Multiple PRP injections also improve 
pain and function in comparison to multiple HA injections or single PRP injections.  
Conclusion: The existing clinical studies show promising data that PRP is a more effective 
treatment for early knee OA in comparison to HA, but further studies need to be performed for 
more conclusive results.  
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INTRODUCTION 
Osteoarthritis (OA) is a gradually progressive degenerative joint disease due to the loss 
and destruction of cartilage from an inflammatory process, most commonly affecting the elderly. 
OA results in pain, decreased joint range of motion, and significantly affect activities of daily 
living and quality of life when severe.1 Two hundred and fifty million people worldwide suffer 
from knee OA, of which 27 million are Americans.2 This number is expected to increase with the 
continued growth in the geriatric population due to the baby boomers.  
In view of the morbidity from OA, the goals of treatment often include pain relief, 
reducing inflammatory signs, and restoring function. Current clinical practice uses various 
conservative treatment options to achieve these goals prior to resorting to total knee arthroplasty. 
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The Osteoarthritis Research Society International (OARSI) most recent guideline for non-
surgical management of knee osteoarthritis recommends first-line treatment as physical therapy, 
including land and water-based exercises, weight management, strength training, and 
biomechanical interventions.3 Physical therapy is often used in combination with medications, 
such as oral and topical non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen. 
However, oral acetaminophen and topical NSAIDs are less effective than oral NSAIDs. 
Unfortunately, many patients cannot tolerate the long-term systemic adverse effects of full-dose 
oral NSAIDs, as doing so may increase the risk for gastrointestinal bleeding or kidney failure. 
Because of these possible complications, oral NSAIDs are contraindicated in patients with 
certain pre-existing conditions such as chronic kidney disease or peptic ulcers.4   
When physical therapy and oral drug therapy fails, standard treatment resorts to a trial of 
injection therapy. Intra-articular (IA) injection therapy has become more popular over the past 
few decades. Corticosteroids are frequently used as the first line and most cost-effective option 
by targeting the inflammatory process of knee OA.4,5 The OARSI recommends IA corticosteroid 
injections, while the American Academy of Orthopaedic Surgeons (AAOS) still finds this 
treatment inconclusive.3,6 Many side effects are associated with corticosteroid injections, such as 
post-injection flare, flushing, facial swelling, skin depigmentation, subcutaneous atrophy, 
articular cartilage changes, increased blood glucose levels in diabetics, osteoporosis, and tendon 
atrophy.5 
Because of the strong side effect profile of IA corticosteroids and the limited number of 
injections a patient can receive in a given time period, researchers have moved onto synthetic 
hyaluronic acid (HA) injections for patients with symptomatic knee OA. HA is endogenously 
produced by the human body, but its levels are decreased in the synovial fluid of OA joints. The 
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principal behind injecting HA into the joint space is to bring the viscoelasticity of the synovial 
fluid back to baseline in an effort to further prevent further degeneration of articular cartilage.5 
Many different brands of HA with varying molecular weights are sold throughout the world, but 
overall, HA is an extremely costly therapy ranging from $750 to $1368.5 In addition, the AAOS 
exercises a strong recommendation against using hyaluronic acid (HA) injections for patients 
with symptomatic knee OA.6  
Platelet-rich plasma (PRP) is another injection therapy that was first introduced in the 
1950s. The application towards OA treatment is still new, with many recent studies attempting to 
explore its efficacy. The appeal of PRP is the ability to use an autologous blood product, rich in 
growth factors and cytokines, that produces anti-inflammatory effects for tissue healing and 
stimulates cartilage regeneration.2 The current AAOS position on PRP injections as a treatment 
for symptomatic knee OA is that the evidence is inconclusive.6  
The question remains, as to which injection therapy is most effective. The purpose of this 
paper is to determine whether current evidence supports the efficacy and superiority of IA PRP 
injections over IA HA injections for improving knee OA pain and function.  
DISCUSSION 
Mechanisms of Action  
The biochemical and biomechanical mechanisms initiated by HA and PRP must be 
understood in order to effectively evaluate the efficacy of HA versus PRP for improving knee 
pain and function. Although both HA and PRP decrease the catabolism of cartilage in OA by 
suppressing inflammatory mediator concentrations, a controlled laboratory study found that PRP 
had a significantly greater reduction of specific protein-coding genes and increased expression of 
other genes to increase cartilage synthetic activity. This study harvested synovium and cartilage 
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from twenty-one patients undergoing total knee arthroplasty and exogenously co-cultured the 
samples in either PRP or HA media.7 The limitation of this study is the small sample size in only 
a population with end-stage, severe OA, resulting in the restricted amount of assays due to the 
minimal amount of knee cartilage available for samples.   
Another controlled laboratory study created cartilage defects in the femoral condyles of 
thirty rabbits and divided them into a PRP, HA, and control group. Histology, growth factors, 
cytokines, and platelet numbers were measured at six and twelve weeks. The PRP group 
exhibited better restoration of cartilage and subchondral bone compared to HA and placebo.8 The 
strengths of this study include its significant results and being able to analyze histological 
samples of the cartilage. However, the limitations include the small animal sample size and the 
short duration of the study.  
In a controlled laboratory study where cells from articular cartilage and synovium of the 
knee were isolated from twelve patients undergoing anterior cruciate ligament reconstruction and 
combined with PRP culture media and control groups. Results showed that PRP significantly 
stimulated both cell proliferation and secretion of superficial zone protein, which lubricates 
articular cartilage, over the control group. These changes decrease the amount of friction and 
bone on bone pain of knee OA.9 Although this study highlights PRP effects on more mild forms 
of OA in humans, the limitation includes small sample size without a comparison to HA.  
A double-blind, randomized clinical trial conducted from a sample size of 336 patients 
with knee OA showed that PRP in comparison to placebo was able to reduce the amount of 
inflammatory and pro-angiogenic factors, thus decreasing both joint inflammation and synovial 
degeneration in patients with knee OA. PRP also promoted neovascularization and decreased the 
damaged cartilage areas in these patients. This study also focused on the pharmacokinetic 
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analysis of PRP and found its most optimal dosage to be 10 milliliters and peak concentration at 
12 hours post-treatment, which is relatively quick compared to other forms of injection therapy.10 
Although this study does not compare PRP to HA, it was able to incorporate a satisfactory 
sample size with a placebo group in a human trial and use MRI analysis to further support the 
positive effects of PRP.  
Knee Pain and Function Efficacy 
As much as HA and PRP can modify growth factors, cytokines, histology of synovial 
fluid and knee joint analysis via MRI or CT, the efficacy of these treatments is better measured 
through patient improvements in knee pain, function, and overall quality of life. Commonly 
accepted tools for measuring these changes are the Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC) pain, stiffness, and physical function scales, Visual Analog 
Scale (VAS) for pain, Knee Society’s Knee Scoring System (KSS), Knee and Osteoarthritis 
Outcome System (KOOS), International Knee Documentation Committee (IKDC) subjective 
knee evaluation, and the Lysholm knee score.  
The WOMAC, VAS, and IKDC scales were used to measure the efficacy between PRP 
and HA in a level I, prospective, randomized, double-blind, comparative clinical trial in 111 
patients with mild to moderate knee OA. PRP was statistically and clinically more effective than 
HA.11 Similarly, a level II, prospective, comparative study with 150 patients not only showed 
improvement of symptoms and function of knee OA in the PRP group compared the HA group, 
but also showed evidence of the longer efficacy with PRP injections.12  
A retrospective study that focused on 118 patients with early knee OA comparing pre-
treatment KSS and VAS scores with post-treatment scores at three and six months, showed that 
PRP was statistically more efficacious than HA.1 In another prospective, randomized study of 
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120 patients with mild to moderate knee OA, followed at baseline, one month, three months, six 
months, and twelve months with WOMAC and VAS scales, PRP compared to HA was found to 
be superior. In addition, the PRP patients experienced at least 12 months of pain reduction.13 
Although most studies indicated that PRP was more effective than HA, a few studies did 
not confirm that PRP was clinically superior to HA for improving pain and function scores. 
Evidence for the superiority of PRP over HA for middle-aged patients with moderate to severe 
knee OA is inconclusive.14,15 
PRP + HA Combination Treatment 
Given that PRP and HA target different factors biochemically and that the evidence is 
inconclusive for PRP superiority to HA in all levels of knee OA, researchers have considered 
whether combination treatment with PRP and HA might provide a more effective treatment for 
knee OA. A small, novel, laboratory study that created an in vivo arthritic cell by sampling 
human chondrocytes and combining the sample in either, a control, HA, PRP, and HA and PRP 
medium focused on the cellular-level benefits of the combination IA injections with HA and 
PRP. The synergistic effects of HA and PRP yielded increased stimulation of cartilage 
regeneration through chondrogenic signaling recovery to rescue cartilage from breakdown and 
decreased the number of inflammatory cells from pro-inflammatory cytokine-induced 
degeneration when compared to the other groups.16 Similarly, another small study showed that 
HA increased the release of important growth factors from PRP.17 However, both studies only 
sampled a small population and analyzed a limited amount of growth factors over a matter of 
days, rather than months.   
Combination PRP and HA treatment is further supported in a double-blind, randomized, 
controlled prospective study of 120 patients divided into groups comparing the combination 
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treatment of HA and PRP to HA or PRP alone via the WOMAC and VAS questionnaires 
completed by participants at baseline and after treatment at 30, 90, 180, and 360 days. The 
combination group showed significantly less pain and improved functional outcomes in the first 
thirty days of treatment and improvements persisted from three months to a year.18  
Multiple PRP Injections 
The optimal number and frequency of PRP injections that are safe and effective are not 
well established. In clinical practice, IA corticosteroid injections are usually given no more 
frequently than every three months, although pain relief is patient dependent and may last only 
one to two months. IA HA injections are usually performed no more than every six months and 
tend to provide relief for a minimum of a few months.  
In a double-blind, randomized, placebo-controlled trial of 182 participants with early 
knee OA, multiple PRP injections led to much better clinical results in comparison to one PRP 
injection, multiple HA injections, or multiple saline injections. However, remarkably no 
significant differences among the four groups were noted for patients with advanced knee OA.19 
On the other hand, a prospective, randomized study found that annual repetition of IA PRP 
injections further improved pain and function, which outcomes were somewhat comparable to 
the sustained pain relief with HA injections every six months.20 
Summary of the Findings 
Although the existing evidence shows that both HA and PRP play a role in improving 
inflammation and growth factors in knee OA, relieving pain, and improving function, studies are 
supporting the use of PRP over HA in the younger population and in those with mild knee OA. 
However, PRP is not more effective than HA in more advanced knee OA. The strengths of these 
studies include the strong level of evidence, good sample size, and variability in age and severity 
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of OA in the sample populations. The limitations of these studies include the lack of a control 
group in the prospective and retrospective studies based on ethical reasons and the absence of a 
comparison group with IA corticosteroid injections. Moreover, self-reported questionnaires 
measuring pain and function are subjective. Yet, obtaining radiographic images for follow-up to 
provide a more objective analysis are not commonly a part of these studies due to high financial 
costs. There were also a number amount of patients from the larger studies that were lost to 
follow-up. Most studies also had a short follow-up period and focused on monitoring treatment 
efficacy for only the first six months to one year following treatment. No long-term studies are 
currently available.  
Evidence from these studies also showed that multiple IA PRP injections performed 
better than either multiple IA HA injections or single PRP injections. In addition, combination 
therapy of HA and PRP seemed to have a synergistic effect resulting in a greater improvement in 
the biochemical properties of knee OA, as well as providing symptomatic relief. Although these 
specific studies are promising, they are few in number. More research is needed to explore PRP 
injections and to determine a proper injection algorithm.   
CONCLUSION 
PRP does have a role in knee OA treatment, especially in younger patients with mild OA 
and in combination therapy with HA, but more research is needed to confirm these conclusions. 
With the pharmaceutical industry’s release of new HA drugs and an extended-release IA 
corticosteroid that has less adverse effects, additional and more comprehensive research 
comparing all IA injection therapies will be necessary. Another factor important in drug selection 
is cost. Although HA injections are more expensive than PRP injections, most insurances 
currently cover HA injections with prior authorization from a clinician, whereas, PRP is mostly 
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cash-pay and not part of the insurance formularies. Moreover, not every clinical practice may 
have the means to afford PRP training of clinicians and the purchase of necessary supplies. 
Another important consideration is whether primary care physicians, as well as sports medicine 
physicians and orthopedic surgeons, can also offer PRP for OA treatment. However, these 
considerations will not be addressed until further research is conducted to establish the efficacy 
of PRP in standard clinical practice guidelines.   
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